Moderna stock tumbles after quarterly earnings show revenue declines: Istoricul versiunilor

Legendă: (actuală) = diferențe față de versiunea curentă, (prec) = diferențe față de versiunea precedentă, M = modificare minoră

8 noiembrie 2023

  • actualăprec 17:258 noiembrie 2023 17:25Admin discuție contribuții 1.103 octeți +1.103 Pagină nouă: <p style="text-align: justify;"><br></p><p style="text-align: justify;">Previously, the COVID-19 vaccine maker estimated end-of-year revenue would land at $21 billion. But, on Thursday, it changed those expectations to between $18 and $19 billion. The company cited supply chain issues that have delayed its vaccine distribution for the revenue decline. Overall third-quarter net income for Moderna stands at $1.043 billion, down from $3.333 billion, or $7.70 a share, from the...